The U.S. Food and Drug Administration issued letters to several companies -- including major pharmacy chains -- this week, warning them against manufacturing or selling unapproved eye products.
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. 2025 got ...
On April 19, 2024, in Tucson, Arizona, amidst 95-degree weather, an 88-year-old woman, speaking primarily Russian, arrived at our office on her motorized scooter, seeking assistance. Believing her ...
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. During the ...
The Food and Drug Administration (FDA) sent warning letters to some health care companies – including CVS Health and Walgreens Boots Alliance – for marketing unapproved eye products. The letters claim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback